Kouta Niizuma
Harvard University, Massachusetts General Hospital, University of Tsukuba, Stanford University
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Hematopoietic Stem Cell Transplantation · Pluripotent Stem Cells Research · Mesenchymal stem cell research
About
My primary research focus is on elucidating the underlying mechanisms of immune system functionality and pioneering technologies to modulate human immune responses. My extensive academic and research background has equipped me with profound expertise in Immunology, Biochemistry, and Stem Cell Biology. Under the mentorship of Professor Akira Shibuya, my early research aimed at dissecting the activation dynamics of innate immune cells, specifically focusing on the CD300/MAIR family receptors. Our research identified the critical role of the mouse Myeloid-associated immunoglobulin-like receptor II (MAIR-II) in bacterial clearance. Translating these findings to human biology led to the identification of CD300H, a novel CD300 family member, and the development of a monoclonal antibody via hybridoma technology. My subsequent research under Professor Lewis L. Lanier involved investigating the NKG2D receptor's role in NK cells during viral infections, enhancing my skills in immunological assays and transplantation models. Currently, under the guidance of Professor Hiromitsu Nakauchi, my research integrates principles of immunology and stem cell biology to develop innovative therapeutic strategies. Significant accomplishments include generating lung cancer neoantigen-specific iPSC-derived T cells, developing monoclonal antibodies for HLA-A, and pioneering scalable macrophage production from Hematopoietic Stem/Progenitor Cells (HSPCs).
Employment
-
Harvard University Instructor in Surgery2026 - Present
-
Massachusetts General Hospital Instructor2026 - Present
-
Stanford University Basic Life Research Scientist2024 - 2026
-
Stanford University Postdoctoral Fellow2018 - 2024
Education
- 2013 - 2018
- 2009 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (14)
- Donor-targeted anti–HLA-A2 antibody shows nanogram-level efficacy in a novel GVHD mouse model Save
- Dysregulated Microglial Synaptic Engulfment in Diffuse Midline Glioma Save
- Xenophagocytosis blockade enhances interspecies chimerism Save
- Donor-Targeted Anti-HLA-A2 Antibody Shows Nanogram-Level Efficacy in a Novel GVHD Mouse Model Save
- Development of iPSC-Derived T Cells Targeting EGFR Neoantigens in Non-Small Cell Lung Cancer Save
- Elevated hematopoietic stem cell frequency in mouse alveolar bone marrow Save
- Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells Save
- Annexin A5 inhibits mast cell activation via Allergin-1 immunoreceptor Save
- Physioxia improves the selectivity of hematopoietic stem cell expansion cultures Save
- Bioluminescent Tracking of Human Induced Pluripotent Stem Cells In Vitro and In Vivo Save
- A microRNA expression and regulatory element activity atlas of the mouse immune system Save
- Cutting edge: NKG2D signaling enhances nk cell responses but alone is insufficient to drive expansion during mouse cytomegalovirus infection Save
- Identification and characterization of CD300H, a new member of the human CD300 immunoreceptor family Save
- Toll-like receptor 4 and MAIR-II/CLM-4/LMIR2 immunoreceptor regulate VLA-4-mediated inflammatory monocyte migration Save